• Nenhum resultado encontrado

EARLY DIAGNOSIS AND MANAGEMENT OF NEUROMYELITIS OPTICA PREVENTS RELAPSES AND LIMITS VISUAL DISABILITY

N/A
N/A
Protected

Academic year: 2017

Share "EARLY DIAGNOSIS AND MANAGEMENT OF NEUROMYELITIS OPTICA PREVENTS RELAPSES AND LIMITS VISUAL DISABILITY"

Copied!
5
0
0

Texto

Loading

Imagem

Table 1: Wingerchuck et al Revised Diagnostic Criteria for NMO
Fig. 1: T2 W coronal view  MRI brain image showing

Referências

Documentos relacionados

Over a period of 65 years, our systematic literature search resulted in 10 patients, in whom MS was worsened and nine in whom MS or neuromyelitis optica was first diag- nosed in

— Pattern shift visual, brainstem auditory, and short latency somatosensory evoked potentials in multiple sclerosis.. — Visual evoked responses in the diagnosis and management

Abstract – Objective: To determine the seroprevalence of neuromyelitis optica antibody (NMO)-IgG in Brazilian patients with clinical diagnosis of relapsing neuromyelitis optica,

Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel- based morphometry study.. Jacob A, McKeon A, Nakashima I,

Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.. Espasmos tônicos são manifestações clínicas frequentes em pacientes com

Neuromyelitis optica spectrum disorders (NMOSD) are characterized by severe optic neuritis and/or longitudinally extensive transverse myelitis, and some brain lesions are also unique

Results: 1,599 patients attended the Clinic from 1994 to 2013: 816 with multiple sclerosis (MS), 172 with clinical isolated syndromes, 178 with neuromyelitis optica (NMO), 216

Neuromyelitis optica antibody (or aquaporin-4 antibody) is a well stablished serum marker associated to high-risk neuromyelitis optica syndrome that presents as an